Important notifications related to the company are listed here. Notifications may come from the SEC, exchanges such as the NYSE or NASDAQ or Watchdog Research. Examples of notifications include announcements of bankruptcy proceedings, company name changes, and noncompliance with SEC regulations or exchange rules.
There are no notifications for Trevi Therapeutics at least since 2017.

Peer Group

Peer groups are used by companies to benchmark executive compensation and performance. Each company identifies its own peer group. Peer groups vary from company to company.

Peer Group

Company Ticker Market Cap
Aslan Pharmaceuticals Ltd. * ASLN $156m
Hepion Pharmaceuticals, Inc. * HEPA $120m
Novus Therapeutics, Inc. * NVUS $100m
Recro Pharma, Inc. * REPH $99.5m
FSD Pharma Inc. * HUGE $58.1m
Qualigen Therapeutics, Inc. * QLGN $42.6m
Evoke Pharma Inc. * EVOK $35.4m
Alimera Sciences Inc. * ALIM $33.4m
Trevi Therapeutics, Inc. TRVI $31.3m
Integrated Biopharma Inc. * INBP $31m

Companies Who Named Trevi Therapeutics as a Peer

Trevi Therapeutics is not named as a peer by any company.
* Suggested by Watchdog.


Peer Flag Comparison

The return to a company’s stock is not the only measure of executive performance. Ethics matter, and growth can quickly reverse and gains evaporate if a company’s accounting and financial reporting processes are not fundamentally sound and trustworthy. How does Trevi Therapeutics' accounting quality compare to its peer group?

Full Watchdog Reports are written for serious investors and professionals and are available through a paid subscription. Get the full details for each company's flags including detailed explanations and links to that company's original public disclosures for yellow or red flags (via SEC, regulatory or legal filings). These underlying documents give you a more complete understanding for each flag event.

View pricing & subscribe

If you would like to see what a Full Company Report looks like, we allow free unrestricted access for General Electric Co [GE]